First Citizens BancShares Inc vs InMode Ltd — how do they compare? First Citizens BancShares Inc trades at $2,066.27 (market cap $22.95B), while InMode Ltd trades at $14.07 (market cap $806.05M). The key difference: First Citizens BancShares Inc is far larger — about 28.5× InMode Ltd's market cap, and First Citizens BancShares Inc pays a 0.41% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold First Citizens BancShares Inc for 29 Days and InMode Ltd for 29 Days on average.
| FCNCA | INMD | |
|---|---|---|
Market Cap | $22.95B | $806.05M |
Volume | 65,288 | 511,446 |
Sector | Sector/Thematic | Health |
52-Week High | $2.29K | $16.62 |
52-Week Low | $1.64K | $12.76 |
Typical Hold Time | 29 Days | 29 Days |
Dividend Yield | 0.41% | — |
Enterprise Value | — | $309.39M |
Signals from Pluang's Aura AI — not financial advice
First Citizens BancShares (FCNCA) trades at $2,071.56, down 0.79% on the day, with a bearish technical signal driven by moving averages. The stock shows strong fundamentals, with a P/E of 11.11 and net income margin of 25.23%, and has beaten EPS estimates for the last three quarters. Recent corporate actions include a $2.10 dividend and expansion through branch acquisitions and new financing initiatives.
The outlook is mixed: solid profitability and earnings beats support upside toward the $2,290 consensus price target, but near-term technical weakness and high institutional hold ratings suggest caution. Key risks include execution of growth initiatives and broader economic pressures on banking.
INMD trades at $14.01, showing minimal daily movement with a 0.14% gain. The stock faces bearish technical signals despite attractive valuation metrics including a P/E of 11.58 and EV/EBITDA of 4.43. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing, while the company faces shareholder activism from Steel Partners' $16.75 per share acquisition offer. Revenue guidance for 2026 remains stable at $365M-$375M.
The investment case balances strong profitability margins against technical weakness and activist pressure. With 45% analyst buy ratings and no sell recommendations, fundamental value appears intact, but near-term price action suggests caution. Key catalysts include Q3 2026 earnings and resolution of the acquisition proposal, while risks include execution challenges and macroeconomic headwinds affecting aesthetic medicine demand.
Trailing returns across standard periods
Latest headlines on both assets
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →